EP1027426A4 - Methode für verbessertes mischen einer varicella-infizierten zellkultur in rollflaschen - Google Patents

Methode für verbessertes mischen einer varicella-infizierten zellkultur in rollflaschen

Info

Publication number
EP1027426A4
EP1027426A4 EP98956229A EP98956229A EP1027426A4 EP 1027426 A4 EP1027426 A4 EP 1027426A4 EP 98956229 A EP98956229 A EP 98956229A EP 98956229 A EP98956229 A EP 98956229A EP 1027426 A4 EP1027426 A4 EP 1027426A4
Authority
EP
European Patent Office
Prior art keywords
varicella
bottle
cell culture
improved mixing
rotary agitator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98956229A
Other languages
English (en)
French (fr)
Other versions
EP1027426A1 (de
Inventor
Joye L Bramble
James A Searles
Fernando J Muzzio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727130.8A external-priority patent/GB9727130D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1027426A1 publication Critical patent/EP1027426A1/de
Publication of EP1027426A4 publication Critical patent/EP1027426A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/10Rotating vessel
    • C12M27/12Roller bottles; Roller tubes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16Vibrating; Shaking; Tilting

Definitions

  • roller bottle systems still prevail in research and industry. Additionally, for industrial scale production of cell culture products (i.e. vaccines), cells are frequently passaged in roller bottles prior to transfer to microcarrier cultures for the final growth phase even when unit operation based systems are utilized [V. G. Edy, Adv. Exp. Med. Biol. 172, 169 (1984)].
  • roller bottle Widespread use of the roller bottle is due to several reasons. Most notably, the process relies on very simple technology: a horizontal cylindrical vessel is filled approximately one-third full and axially rotated. Thus, scale-up development is not required, resulting in reduced developmental timelines for industry and faster introduction to market for new products.
  • the system allows constant fluid-gas contact, and easy addition of nutrients without interruption of the process.
  • the process is capable of maintaining sterile conditions for prolonged times, contamination of one or more roller bottles does not result in the contamination of an entire lot, precise control of nutrient and waste-product levels is possible, and the direct monitoring of the cells is relatively simple [E. I. Tsao, M. A. Bohn, D. R. Omstead, and M. J. Munster. Annals N.Y. Acad. Sci. 665, 127 (1992)].
  • roller bottles are limited in surface area available for growth and in the volume of harvest fluid obtained.
  • the instant application describes detail mathematical and experimental characterizations of the fluid flow profiles within rotating roller bottles, including particle trajectories, fluid mixing patterns, and unsteady-state flow strategies.
  • the results point to ways in which cell proliferation and infection can be optimized by simple modifications to the roller bottle's rotation.
  • the instant invention describes an improved method for mixing of a varicella-infected cell culture in roller bottles that introduces cross-sectional flow perturbations. These perturbations disrupt the closed orbits that cells experience during conventional mixing and facilitate particle settling.
  • this invention relates to a mixing process that ensures that cells come in contact with adequate amounts of nutrient-rich medium and by increasing the contact between the cells and the roller bottle wall or cell sheet and thereby enhances productivity.
  • This invention relates to a method for enhancing the mixing of a varicella-infected culture in a roller bottle by the introduction of controlled cross-sectional flow perturbations.
  • the effectiveness of the method is demonstrated by achieving higher efficiency in cell culturing and virus propagation in roller bottles.
  • Figures 4a shows the initial condition
  • Fig. 4b through 4e represent the initial condition and the line after 4, 8, 16, and 32 bottle revolutions, respectively.
  • the colors in this figure range from dark blue to red, and correspond to zero residence time to infinite residence time.
  • Quantity of infectious foci on the cell monolayer as a function of rotation rate.
  • FIG. 20 Experimental apparatus used to investigate mixing enhancement via introduction of rocking motion.
  • Figure 21(a)-21(c) demonstrate axial mixing with no rocking after 0, 32 and 64 revolutions, respectively.
  • Roller machine capable of introducing a rocking motion.
  • Figure 23 Protuberances on (a) the roller bottle and (b) rollers which introduce a rocking motion.
  • the invention relates to a method for enhancing the mixing of a varicella-infected cell culture in a roller bottle comprising controlled cross-sectional flow perturbations in roller bottle rotation.
  • a mode of enhancing mixing and settling is to use a combination of rotation and rocking.
  • the axis of rotation of the roller bottle is the axis defined by the line connecting the center of the roller bottle and running the length of the roller bottle.
  • the rocking motion is defined as the angle swept by the roller bottle about an axis that is perpendicular to the axis of rotation of the roller bottle, that angle of about 0 degrees to about + 20 degrees or -20 degrees, a speed of rotation of about 0 to about 50 rpm, and a rock to roll frequency of about 0 to about 31.4.
  • the preferred conditions for the combined rotation of the bottle with rocking motion are defined by a rocking angle of about +10 degrees to about -10 degrees, and a rock to roll frequency of about 1.8.
  • rocking motion can be introduced in a number of ways, including but not limited to, introducing a rocking motion to a roller machine ( Figure 22), or by introducing protuberances to the rollers or the roller bottles ( Figure 23).
  • the roller machine rack as depicted in Figure 22 provides the most flexibility in varying the rock to roll frequency, rocking angle, frequency of bottle rotation and the speed of rotation. Additionally, a single level roller machine is also contemplated by the instant invention. Time-Dependent Rotation Speed Of The Roller Bottle
  • Another way of disturbing periodic cell trajectories is to operate the bottle in a stop-go mode.
  • the bottle motion consists of two alternating parts.
  • the bottle is rotated at constant velocity U for a time t 1? and then it is kept stationary for a time t 2 .
  • cells undergo settling at terminal speed.
  • the purpose of using this mode is to try to break the periodic cell orbit and let cells settle.
  • Another approach is to vary the speed of rotation as a function of time. This approach has been applied to the varicella vaccine production process. Previously, the method had utilized a rotation rate of 0.25 rpm throughout. Experiments were conducted with faster rotation rates for the cell expansion phase and slower rotation rates for the first 6 hours of the infection phase. As described below, slower rotation rates during the virus propagation phase enabled more varicella-infected cells to reach the inside surfaces of the roller bottle sooner, resulting in higher levels of virus production. In addition, rotation faster than 0.25 rpm during the cell expansion phase resulted in more efficient cell growth.
  • the method for enhancing the mixing in a roller bottle wherein the controlled axial flow perturbation is introduced by combining a time-dependent rotation speed of the roller bottle with a rocking motion, which is further defined by a speed of rotation of about 0 to about 50 rpm, a frequency of rotation rate changes per revolution of about 0 to about 1, a rocking angle of about 0° to about +10 degrees or -10 degrees, and a rock to roll frequency of about 0 to about 31.4.
  • the method for mixing in a roller bottle wherein the controlled axial flow perturbation is introduced by combining a time-dependent rotation direction of the roller bottle with a rocking motion, which is further defined by a speed of rotation (roll frequency) of about 0 to about 50 rpm, and a frequency of rotation direction changes per revolution of about 0 to about 1, a rocking angle of about 0° to about +10 degrees or -10 degrees, and a rock to roll frequency of about 0 to about 31.4.
  • the method for mixing in a roller bottle wherein the controlled axial flow perturbation is introduced by combining a time-dependent rotation direction of the roller bottle with a rocking motion and a time-dependent speed of rotation, which is further defined by a speed of rotation of about 0 to about 50 rpm, and a frequency of rotation direction changes per revolution of about 0 to about 1, rocking angle of about 0° to about +10 degrees or -10 degrees, and a rock to roll frequency of about 0 to about 31.4.
  • Typical parameters and preferred values are the following: for rotation frequency, 0 to 50 rpm, 0.1 to 5 rpm preferred; for rocking angle, 0 to ⁇ 20 degrees, 0 to ⁇ 10 degrees preferred; for the magnitude of rotation speed variations, the low speed is 0% to 100% of the high speed, preferred value is when the low speed is less than or equal to 50% of the high speed; for the frequency of rotation speed variations, from 0 to 10 times the frequency of rotation, from 0.05 to 0.5 times the frequency of rotation is preferred; and for the frequency of rotation direction variations, from 0 to 2 times the frequency of rotation, 0.5 is the preferred value
  • the term "materials” refers to the a solution of or suspension of liquid and solid materials, such as a cell culture and the media needed to sustain that culture, the virus infected cells and the media needed to sustain these cells.
  • a specific example of 'materials' are the MRC-5 cells and the varicella-infected cells utilized in Examples 4-6.
  • the instant invention can be understood further by the following examples, which do not constitute a limitation of the invention.
  • V u 0 . (2)
  • the rationale for selecting liquid height as natural length scale for the flow is that the liquid height is the diffusional length scale in the system. Viscous forces can be viewed as diffusive transport of momentum, with the kinematic viscosity ( ⁇ p) playing the role of a momentum diffusivity.
  • the liquid depth is the natural length scale for the action of viscous forces.
  • the physical domain was discretized using a curvilinear mesh; while the bottle has a total length to diameter ratio of 2:1, due to the symmetry of the roller bottle, only one-half of the system needed to be simulated, giving a length to diameter ratio of 1:1.
  • the liquid height in the bottle was one-third the total diameter, which was consistent with industrial practice.
  • a 80 x 20 x 94 structured computation grid is used;
  • Figure lb represents a schematic of the z-plane grid (for the computation a higher node density was used).
  • An acceptable node density for the computational mesh was found by creating several meshes with different node densities. The number of nodes in the mesh was successively increased by 25% until an average velocity difference of less than 3% was achieved for two successive meshes. The lower node density was then used to generate the computational mesh.
  • Velocity and pressure fields were obtained via iteration using a Sun SPARC 20 workstation. Approximately 140 Mb of RAM and 60 hours of CPU time were need for solution convergence. In order to determine convergence, a criterion of 10"6 was used for each normalized residual velocity and pressure component. Residuals for each iteration were normalized versus the residual values obtained after the second iteration of the solver. In order to test the sufficiency of the convergence criterion, the simulation was run using convergence criteria ranging from 10"5 to 10" ⁇ with no significant change in the velocity field when the convergence criteria was varied over this range ( ⁇ 1.0% change in velocity magnitude, on average). Sensitivity analysis (i.e., trajectory closing) showed that such a mesh is sufficiently accurate.
  • the Fluid Velocity Field in a Roller Bottle Two flow visualization experiments were performed in order to validate the simulations. The experiments were done in a glass roller bottle with 10 cm diameter and 20 cm length. The working fluid was glycerin, which had a density of 1.26 g/cm 3 and a viscosity of 1.25 Pa s. The bottle was rotated using an apparatus which consisted of a set of rollers whose rotation speed and direction was accurately controlled by a computer. The rotation rate for the two experiments performed was 0.25, giving a Re of 0.04, which is well within the creeping flow regime. The velocity field was first validated via comparison with PrV results. The use of particle imaging techniques to study fluid flow problems is well-documented in the literature and reviewed by R.J. Adrian, Ann. Rev.
  • the experimental velocity field was measured at the vertical plane in the middle of the bottle.
  • Figure 2a,b respectively show the experimental (2a) and computational (2b) velocity vector fields.
  • the length and color of the arrows represent the velocity magnitude in the plane, ranging from low (dark blue) to high (red).
  • the velocity fields are qualitatively identical, with the exception of some small experimental scattering near the free surface of the liquid.
  • the computational velocity field was further validated by comparing computational and experimental mixing patterns obtained for passive tracers at the center plane of the bottle. This first step for simulating mixing patterns is to determine the trajectories followed by point particles as a result of the equation of motion
  • FIG. 3 shows the flow particle pathlines predicted using 4th order Runge-Kutta integration of equation (3), which are also the flow streamlines since the flow is steady and the particles follow the flow passively. There is a stagnation point located on the symmetry line at 0.6 unit lengths below the free surface (the unit length is the height of the liquid).
  • Fig. 4a The line consisted of 10,000 particles moving at the flow velocity.
  • Figures 4b-4e show the configuration adopted by the line, as revealed by the particle positions, at 4, 8, 16, and 32 bottle revolutions.
  • Figure 7f corresponds to the center of the bottle and is therefore identical to Fig. 2b Moreover, Fig. 7d and 7e are also identical to Fig. 7f, indicating that end effects play little or no role in the fluid flow past 5 cm from the end of the bottle.
  • the velocity field shows both especular symmetry relative to the center plane (expected from the symmetry of the boundary) and antisymmetry between the left and right sides of the bottle (expected from the creeping flow condition and the rotational symmetry of the bottle). As discussed below, this observation can have important implications, because the flow induced by the ends of the bottle is the only means of axial mixing.
  • Figure 7a represents the velocity field at the end of the roller bottle. Due to the no-slip condition at the bottle wall, all fluid follows the bottle wall in a counter-clockwise direction. When the fluid reaches the free surface (at the right side), it detaches from the wall and flows outward in the z-direction. At the left side, the fluid immediately adjacent to the wall is drawn downward; this motion is "fed” by an inward flow from the z-direction.
  • Figures 7b and 7c show the presence of a high velocity component near the surface of the liquid, caused by the end effects. However, detailed examination of the velocity vectors displayed in Fig.
  • FIG. 7b-c indicate that the x and y components of the velocity field are largely unaffected by end effects; such effects appear primarily in the axial (z) component of the velocity field.
  • the end-wall effects are more clearly shown by a top view of the bottle.
  • Figure 8 shows a velocity contour plot just below the liquid free surface. The end of the bottle is at the bottom of this figure, and the symmetry plane is at the top. Flow in the axial (z) direction is clearly visible in this figure. The fluid flows upward from the end wall in the lower right-hand corner travels in a counter-clockwise loop, then flows downward at the lower right-hand corner due to the end-wall flow. There is a stagnation point 0.46 cm from the end of the bottle, as shown in the dark blue color. Moving toward the center of the bottle, end effects have less effect on the flow; there is less than 2% difference in the velocity field between the 2-D symmetry plane and the plane at 5 cm from the end wall. The surface flow in this region is from right to left.
  • FIG. 9 shows six pathlines for fluid particles initially placed 0.2 cm from the bottom of the bottle.
  • the center of the bottle is at the left- hand side of the figure, and the end wall is at the right. Looking at the pathlines from left to right, we see the effect that the end wall has on the flow field.
  • the pathline at the center plane is a two-dimensional vertical loop identical to the pathlines observed in Fig 3. As we move toward the end of the bottle, the pathlines begin to bend near the free surface toward the center of the bottle. All the pathlines shown are closed loops.
  • the pathlines at the center plane of the bottle are two-dimensional loops, and the pathlines away from the symmetry plane are three-dimensional loops.
  • u is the fluid velocity vector
  • v is the cell velocity vector
  • a is the cell radius
  • v is the fluid kinematic viscosity
  • m p and mp respectively correspond to the weigh of the cell and that of the fluid displaced by the cell.
  • the five terms in the right hand side of the equation correspond to buoyancy forces, pressure forces, flow history effects, added mass effect, and Stokes drag forces. This equation can be significantly simplified for the roller bottle problem. Since u is known from the numerical solution of the flow, the relative magnitude of each term can be evaluated. Analysis has shown that the leading order terms are inertia, buoyancy, and drag forces, thus the equation becomes:
  • FIG. 11 closely resembles the pattern shown in Figure 10, which is a simulation for particles of roughly similar settling velocity.
  • Figure 10 is a simulation for particles of roughly similar settling velocity.
  • the particle was originally placed in a different location, closer to the bottle center, the particle followed a different closed pathline.
  • the particle When placed close enough to the upper surface, the particle eventually settled and remain attached to the bottle wall.
  • 0.2U, Fig. 12e are most particles able to reach the bottle walls. Although such simulations give information about the dynamical behavior of particle motion, the settling rate can not be inferred from them.
  • the colors from dark blue to red represent the particle residence time from 0 to the maximum computing time.
  • the rate of particle settling is shown in Fig. 14.
  • the periodic flow can be simulated with two identical steady flows that are mirror images of each other, each one acting for a predetermined amount of time in an alternating fashion.
  • T the flow period
  • T ⁇ 25 the bottle does not complete a rotation between reversals, and therefore some regions of the bottle wall never touch the liquid. Such a condition would lead to starvation and death of cells in such regions of the bottle wall, and therefore to reduced process efficiency.
  • Figures 21a-c show the results of this experiment.
  • the initial condition is shown in Figure 21a
  • mixing after 32 revolutions is shown in Figure 21b
  • mixing after 64 revolutions is shown in Figure 21c.
  • Frozen MRC-5 cells were thawed, and the cells were cultivated in either T-flasks or Nunc Cell Factories, which are flat, stationary growth surfaces. The cells attached to and propagated on the lower surfaces of these containers, where they were submerged under a nutrient growth medium. Every 6 days, the cells were removed from the surface by enzymatic means, known as trypsinization. The resulting cell suspension was then diluted and placed into a larger number of vessels for further propagation. On day 27 of the process, the freshly trypsinized, concentrated cell suspension was then placed in the roller bottles along with 125 mL of growth medium. The bottles were rotated at 0.25 rpm or 0.5 rpm and incubated at 37 °C.
  • the higher cell yield is obtained by a prolongation of the exponential growth phase. See Figure 18, which depicts the daily growth curves for two of the five trials. The figure illustrates that the higher cell numbers are not due to a higher growth rate, rather the exponential growth phase of the culture has been extended. This may be attributable to improved transport of nutrients, gases, and waste products resulting from the faster rotation.
  • Roller bottle cultures from Trials 4 and 5 above were then infected by the addition of freshly trypsinized, virus-infected MRC-5 "working seed” cells.
  • the virus infected cells were added to the liquid nutrient medium in the roller bottle, where they attached to the uninfected cell monolayer which had been established on the inside surfaces of the roller bottle. Once the bottles were inoculated with the "working seed", they were rotated at alternate rates.
  • the table below describes the normalized results from the experiments.
  • the potency was evaluated by five replicate plaque assays for each of the four experimental groups, for each of the two experiments.
  • the combination strategy of the faster rotation for cell growth and slower rotation for the initial period of infection resulted in 32 % more product, with a 95% confidence interval of 15%, indicating a statistically significant result.
  • the rotating bottle creates circular liquid flows, in which the varicella-infected cells can become "trapped.” As these infected cells circulate in the liquid phase, they gradually lose their infectivity (the 1/2-life of the infectivity is less than 5 hours). Although slowing the rotation rate of the bottles does not break up the circular flows, modeling had shown that it would allow more of the trapped cells to reach the surface sooner via settling, as borne out by these experiments.
  • Figures 15 through 17 illustrate that a slower rotation rate results in faster transport of infected cells to the cell culture which has been established on the inner surfaces of the roller bottle. It is important to minimize the length of time which the infected cells spend in the culture supernatant for two reasons. First, time in the supernatant is process time during which a given virus-infected particle is not infecting the cell monolayer, and thus, generating product. Second, the half life of the virus activity less than 5 hrs. Time spent in the supernatant translates directly into degraded viral material.
  • Figures 15 and 17 show the numbers of infected cells present in the supernatant through time for several different rotation rates.
  • Figure 15 shows that at a faster rotation rate of 1/2 rpm, more infected cells are left in the supernatant relative to the regular production (1/4 rpm) and T-flask stationary controls.
  • Figure 16 confirms that the disappearance of infected cells from the supernatant correlates with the appearance of infectious foci on the cell monolayer. For all cases, the faster rpm resulted in fewer infectious foci per unit area.
  • Figure 17 shows similar data for an experiment which tested 1/4, and 1/8 rpm, where the slower rpm again resulted in enhanced transport of infected cells to the surface.
  • the technique used for cell enumeration in Figure 17 was much more sensitive than the technique used for cell enumeration in Figure 15, so the 1/4 rpm control cases for the two experiments differ.
  • the Oka strain of varicella was obtained from the Biken Institute, Japan.
  • MRC-5 cells were obtained from ATCC or NIBSC and used to generate a Manufacturer's Working Cell Bank (MWCB) at Merck.
  • MEM was manufactured by Merck and supplemented at the time of use with fetal bovine serum (FBS), neomycin and glutamine.
  • FBS fetal bovine serum
  • HBME was purchased from GIBCO.
  • Horseradish peroxidase- conjugated donkey anti-goat antibody (affinity purified F(ab')2 fragment) was obtained from Jackson Immunoresearch Labs, Inc., West Grove, PA, (Cat# 705-036-147).
  • the goat anti-varicella antiserum was obtained from Lampire, Inc. (Lot 2200).
  • 3,3-diaminobenzidine (DAB) was obtained from Sigma, prepared as a 25 mg/ml solution in water and stored at -
  • MRC-5 ampules (ATCC No. CCL 171) were thawed, and the cells were cultivated in either T-flasks or Nunc Cell Factories, which are flat, stationary growth surfaces.
  • the cells were added to BME medium supplemented with 10% FBS, 50 ⁇ g/mL neomycin, and 2 mM glutamine; and were incubated at 37°C. Every 3 to 9 days (depending upon the exact process), the cells were removed from the surface by enzymatic means using trypsin. The resulting cell suspension was then diluted and placed into a larger number of vessels for further propagation.
  • Freshly trypsinized, concentrated cell suspension was placed in the roller bottles with MEM growth medium supplemented with 10% FBS, 50 ⁇ g/mL neomycin, and 2 mM glutamine. The bottles were incubated at 37 °C and rotated at the desired rate. After 4-6 days (depending upon the process used), the roller bottles were refed with fresh nutrient medium.
  • Roller bottle cultures with an established cell monolayer on the roller bottle surface were infected by the addition of freshly trypsinized, virus-infected MRC-5 cells.
  • the virus infected cells were added to the liquid nutrient medium in the roller bottle 6-8 days after the initial roller bottle cell plant.
  • Samples were thawed in 20-30 °C water with frequent swirling.
  • the sonicator was calibrated so that when the sonicator tip was immersed in 20 mL of room temperature water and energized for 1 minute, the temperature of the water would be increased by 5 °C.
  • the sonicator tip was then sterilized by the application of 90% isopropyl alcohol.
  • the thawed samples were each sonicated for 1 minute in 20 mL aliquots. Sonicated samples were then frozen at -70 °C for potency testing.
  • Varicella Plaque Assay MRC-5 cells were grown in 60 mm plates with 5 ml/plate of
  • BME with 10% FBS, 0.2 % glutamine, and 0.05% neomycin 10 plates were prepared per sample with 5 plates per dilution. The plates were then incubated at 35.5°C with a 3% CO 2 gas environment for 2 days. Prior to addition of the samples, the cell growth medium was removed and 5 ml plate of MEM with 2% FBS, 0.2% glutamine, and 0.05% neomycin was added to each plate. Diluted virus samples of 0.1ml were added to each plate. Samples were diluted to ensure a plaque counting range of 15-80 plaques per plate. The plates were mixed well and incubated for 7 days at 35.5°C with a 3% CO 2 gas environment.
  • the medium was aspirated from the culture vessel (T-flask or roller bottle) using vacuum.
  • the culture vessel was then rinsed three times with PBS with 1% BSA.
  • a fixing solution of 5% acetic acid, 5% water, and 90% methanol was added to the culture vessel and exposed to all surfaces for 15-30 minutes.
  • the methanol was then aspirated from the culture vessel with vacuum.
  • the culture vessels were then rinsed three more times with PBS, and stored with a PBS overlay at 4-8 °C until stained. Immunostaining of the fixed bottles was carried out by a dual antibody method.

Landscapes

  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP98956229A 1997-10-31 1998-10-27 Methode für verbessertes mischen einer varicella-infizierten zellkultur in rollflaschen Withdrawn EP1027426A4 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6444897P 1997-10-31 1997-10-31
US64448P 1997-10-31
US6726497P 1997-12-03 1997-12-03
US67264P 1997-12-03
GB9727130 1997-12-22
GBGB9727130.8A GB9727130D0 (en) 1997-12-22 1997-12-22 A method of improved mixing of a varicella-infected cell culture in roller bottles
PCT/US1998/022716 WO1999023206A1 (en) 1997-10-31 1998-10-27 A method of improved mixing of a varicella-infected cell culture in roller bottles

Publications (2)

Publication Number Publication Date
EP1027426A1 EP1027426A1 (de) 2000-08-16
EP1027426A4 true EP1027426A4 (de) 2006-04-19

Family

ID=27269149

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98956229A Withdrawn EP1027426A4 (de) 1997-10-31 1998-10-27 Methode für verbessertes mischen einer varicella-infizierten zellkultur in rollflaschen

Country Status (5)

Country Link
EP (1) EP1027426A4 (de)
JP (1) JP2001521737A (de)
AU (1) AU742756B2 (de)
CA (1) CA2307832C (de)
WO (1) WO1999023206A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2295465T3 (es) 2002-09-16 2008-04-16 Pan-Biotech Gmbh Procedimiento para el cultivo de celulas, en especial de celulas humanas o de animales.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307965A (en) * 1980-05-30 1981-12-29 Innovative Medical Systems Corp. Mixing apparatus
JPS61138522A (ja) * 1984-12-11 1986-06-26 Matsushita Electric Ind Co Ltd 混合機
US5159694A (en) * 1986-03-14 1992-10-27 Kernforschungsanlage Juelich Gmbh Portable reactor for carrying out gas-evolving biotechnological processes or gas consuming processes while maintaining a packed fixed-bed arrangement
JPH0568533A (ja) * 1991-09-12 1993-03-23 Hitachi Ltd 生物細胞の培養方法
EP0586922A1 (de) * 1992-09-02 1994-03-16 Heraeus Instruments GmbH Kulturgefäss für Zellkulturen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3893887A (en) * 1973-07-09 1975-07-08 Univ Duke Method for rapid harvesting of roller culture supernatant fluid
US3982259A (en) * 1974-12-13 1976-09-21 Edward Van Baerle Photographic material processing module
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
DE2934328C2 (de) * 1979-08-24 1982-04-29 Stephan Dipl.-Chem. Dr.rer.nat. 8000 München Nees Verfahren zur Kultivierung matrixgebundener biologischer Zellsysteme sowie Vorrichtung zur Ausübung des Verfahrens
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
US5026650A (en) * 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307965A (en) * 1980-05-30 1981-12-29 Innovative Medical Systems Corp. Mixing apparatus
JPS61138522A (ja) * 1984-12-11 1986-06-26 Matsushita Electric Ind Co Ltd 混合機
US5159694A (en) * 1986-03-14 1992-10-27 Kernforschungsanlage Juelich Gmbh Portable reactor for carrying out gas-evolving biotechnological processes or gas consuming processes while maintaining a packed fixed-bed arrangement
JPH0568533A (ja) * 1991-09-12 1993-03-23 Hitachi Ltd 生物細胞の培養方法
EP0586922A1 (de) * 1992-09-02 1994-03-16 Heraeus Instruments GmbH Kulturgefäss für Zellkulturen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 010, no. 335 (C - 384) 13 November 1986 (1986-11-13) *
PATENT ABSTRACTS OF JAPAN vol. 17, no. 382 19 July 1993 (1993-07-19) *
See also references of WO9923206A1 *

Also Published As

Publication number Publication date
JP2001521737A (ja) 2001-11-13
EP1027426A1 (de) 2000-08-16
CA2307832C (en) 2005-09-06
AU1280499A (en) 1999-05-24
WO1999023206A1 (en) 1999-05-14
AU742756B2 (en) 2002-01-10
CA2307832A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
FR2650182B1 (fr) Procede de preparation d'une composition pharmaceutique sous forme de microparticules
FR2761618B1 (fr) Composition catalytique et procede pour l'alkylation d'hydrocarbures aliphatiques
FR2603899B1 (fr) Procede perfectionne pour l'expression de recombinants
FR2725919B1 (fr) Composition catalytique et procede pour l'alkylation d'hydrocarbures aliphatiques
AU1574100A (en) Biological nutrient removal using "the olaopa process"
EP0921198A4 (de) Verfahren zum enzymatischen nachweis eines verzuckerungsproteins
FR2697264B1 (fr) Procédé pour réduire la tendance à l'agglomération des hydrates dans les effluents de production.
EP0644887A1 (de) Verfahren zur herstellung von clavulansäure.
FR2560098B1 (fr) Procede d'obtention d'outils diamantes rotatifs, en l'espece fraises pour odontoiatrie, avec zones espacees par des sillons
FR2625749B1 (fr) Agglomere combustible resistant a l'eau, procede pour le preparer et composition de matieres mise en oeuvre dans ce procede
FR2542495B1 (fr) Procede pour l'incorporation de boues dans du cimentÿa
ZA895938B (en) Process for making compost from waste matter present in liquid form,such as liquid manure(slurry),waste water,sewage sludge or the like
EP0658768A3 (de) Verringerung der Hintergrund-Interferenzen im Molybdat-Farbstoff-Protein-Testverfahren.
FR2729678B1 (fr) Monocristaux en solution solide de ktiopo4 et procede pour les preparer
EP1027426A4 (de) Methode für verbessertes mischen einer varicella-infizierten zellkultur in rollflaschen
FR2754710B1 (fr) Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle
TW334419B (en) Inorganic support materials containing sulphonate and mercapto groups
FR2570602B1 (fr) Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
FR2610004B1 (fr) Procede de pre-isomerisation du houblon pour la preparation d'une boisson notamment de la biere
FR2694000B1 (fr) Perfectionnement dans un procede de preparation de tertiobutylphenols.
IT1273396B (it) Unita' di supporto per un tamburo mescolatore, in particolare di una betoniera per calcestruzzo presonfezionato
FR2651676B1 (fr) Paille d'aspiration pour prelevement de produits liquides mouillants, procede et moyens de realisation de cette paille.
FR2605016B1 (fr) Ensemble modulaire pour la manipulation de cultures cellulaires en milieu sterile.
FR2607434B1 (fr) Procede de thermoformage d'une plaque a double paroi entretoisee
EP1027425A4 (de) Methode für verbessertes mischen in rollflaschen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20000531;LT PAYMENT 20000531;LV PAYMENT 20000531;MK PAYMENT 20000531;RO PAYMENT 20000531;SI PAYMENT 20000531

A4 Supplementary search report drawn up and despatched

Effective date: 20060306

17Q First examination report despatched

Effective date: 20060925

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MERCK SHARP & DOHME CORP.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130503